Biomarker-based early cancer detection: Is it achievable?

Science Translational Medicine

Volumn 3, Issue 109, 2011, Pages

  Hazelton, William D ^a   Luebeck, E Georg ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; PROTEOME; TUMOR MARKER;

BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER RISK; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MATHEMATICAL MODEL; MOLECULAR DIAGNOSIS; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TUMOR GROWTH; TUMOR VOLUME; ARTICLE; METHODOLOGY; THEORETICAL MODEL;

EARLY DETECTION OF CANCER; HUMANS; MODELS, THEORETICAL; TUMOR MARKERS, BIOLOGICAL;

EID: 81455138163     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003272     Document Type: Short Survey

References (11)

1. S. S. Hori, S. S. Gambhir, Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations. Sci. Transl. Med. 3, 109ra116 (2011).
2. The U.S. Preventive Services Task Force, Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. http://www.uspreventiveservicestaskforce.org/uspstf12/prostate/prostateart.htm.
3. S. Yachida, S. Jones, I. Bozic, T. Antal, R. Leary, B. Fu, M. Kamiyama, R. H. Hruban, J. R. Eshleman, M. A. Nowak, V. E. Velculescu, K. W. Kinzler, B. Vogelstein, C. A. Iacobuzio-Donahue, Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010).
4. P. O. Brown, C. Palmer, The preclinical natural history of serous ovarian cancer: Defining the target for early detection. PLoS Med. 6, e1000114 (2009).
5. P. M. Das, R. C. Bast Jr., Early detection of ovarian cancer. Biomarkers Med. 2, 291-303 (2008).
6. S. K. Wyman, R. K. Parkin, P. S. Mitchell, B. R. Fritz, K. O'Briant, A. K. Godwin, N. Urban, C. W. Drescher, B. S. Knudsen, M. Tewari, Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 4, e5311 (2009).
7. G. L. Anderson, M. McIntosh, L. Wu, M. Barnett, G. Goodman, J. D. Thorpe, L. Bergan, M. D. Thornquist, N. Scholler, N. Kim, K. O'Briant, C. Drescher, N. Urban, Assessing lead time of selected ovarian cancer biomarkers: A nested case-control study. J. Natl. Cancer Inst. 102, 26-38 (2010).
8. A. Taguchi, K. Politi, S. J. Pitteri, W. W. Lockwood, V. M. Faça, K. Kelly-Spratt, C. H. Wong, Q. Zhang, A. Chin, K. S. Park, G. Goodman, A. F. Gazdar, J. Sage, D. M. Dinulescu, R. Kucherlapati, R. A. Depinho, C. J. Kemp, H. E. Varmus, S. M. Hanash, Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 20, 289-299 (2011).
9. M. S. Pepe, R. Etzioni, Z. Feng, J. D. Potter, M. L. Thompson, M. Thornquist, M. Winget, Y. Yasui, Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst. 93, 1054-1061 (2001).
10. The Early Detection Research Network. http://edrn.nci.nih.gov/docs/ progress-reports/edrn-4th-report-200801.pdf.
11. Cancer Intervention and Surveillance Modeling Network. http://cisnet.cancer.gov.